What is DexCom's notes payable - fair value?

DexCom (DXCM) reported notes payable - fair value of $10.50M in Q1 2026.

How has DexCom's notes payable - fair value changed year-over-year?

DexCom's notes payable - fair value decreased by 5.4% year-over-year, from $11.10M to $10.50M.

Notes Payable - Fair Value

DexCom Notes Payable - Fair Value remained flat by 0.0% to $10.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.4%, from $11.10M to $10.50M.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Liabilities

First reportedQ4 2025

Last reportedQ1 2026

Metric ID: notes_payable_fair_value

Historical Data

6 periods

	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$10.50M	$11.10M	$11.10M	$10.50M	$10.50M	$10.50M
QoQ Change	—	+5.7%	+0.0%	-5.4%	+0.0%	+0.0%
YoY Change	—	—	—	—	+0.0%	-5.4%

Range$10.50M – $11.10M

CAGR+0.0%

Avg YoY Growth-2.7%

Median YoY Growth-2.7%

Current Streak2 quarters growth

Frequently Asked Questions

What is DexCom's notes payable - fair value?: DexCom (DXCM) reported notes payable - fair value of $10.50M in Q1 2026.
How has DexCom's notes payable - fair value changed year-over-year?: DexCom's notes payable - fair value decreased by 5.4% year-over-year, from $11.10M to $10.50M.